These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38769490)

  • 1. Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report.
    Kato J; Okonogi H; Kanzaki G; Katsumata H; Nakada Y; Sagasaki M; Komine K; Ito K; Saito T; Matsunaga A; Tokutou K; Honda K; Tsuboi N; Yokoo T
    BMC Nephrol; 2024 May; 25(1):171. PubMed ID: 38769490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein Glomerulopathy With Complete Resolution With Fenofibrate: Report of First Case From Pakistan.
    Shaker N; Ben Musa R; Shaker N; Nasir H; Kamran TE; Poombal F; Abid A; Abu Shakra R; Mansoor I
    Int J Surg Pathol; 2024 Oct; 32(7):1404-1408. PubMed ID: 38327135
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipoprotein glomerulopathy induced by ApoE-Sendai is different from glomerular lesions in aged apoE-deficient mice.
    Ishimura A; Watanabe M; Nakashima H; Ito K; Miyake K; Mochizuki S; Ishigaki Y; Saito T
    Clin Exp Nephrol; 2009 Oct; 13(5):430-437. PubMed ID: 19459027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein Glomerulopathy, First Case Report from Canada.
    Ting JA; McRae SA; Schwartz D; Barbour SJ; Riazy M
    Int J Nephrol Renovasc Dis; 2022; 15():207-214. PubMed ID: 35761986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America.
    da Silveira-Neto JN; de Oliveira Ahn GJ; de Menezes Neves PDM; Baptista VAF; de Almeida Araújo S; Wanderley DC; Watanabe A; Watanabe EH; Murai NM; Bertollo EMG; Vieira-Neto OM; Dantas M; de Antônio SR; Costa RS; Baptista MASF; Moysés-Neto M; Onuchic LF
    Diagn Pathol; 2021 Jul; 16(1):65. PubMed ID: 34311745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T＞C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy.
    Wu H; Yang Y; Hu Z
    J Atheroscler Thromb; 2018 Aug; 25(8):733-740. PubMed ID: 29398675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate.
    Kodera H; Mizutani Y; Sugiyama S; Miyata T; Ehara T; Matsunaga A; Saito T
    Case Rep Nephrol Dial; 2017; 7(2):112-120. PubMed ID: 28966924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation.
    Hu Z; Huang S; Wu Y; Liu Y; Liu X; Su D; Tao Y; Fu P; Zhang X; Peng Z; Zhang S; Yang Y
    Kidney Int; 2014 Feb; 85(2):416-24. PubMed ID: 24025644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy.
    Qin Y; Sun XJ; Hu YF; Jing M; Yu XJ; Zhao MH; Tan Y
    Ren Fail; 2024 Dec; 46(1):2332491. PubMed ID: 38584145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topics in lipoprotein glomerulopathy: an overview.
    Saito T; Matsunaga A; Ito K; Nakashima H
    Clin Exp Nephrol; 2014 Apr; 18(2):214-7. PubMed ID: 24149835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy.
    Ieiri N; Hotta O; Taguma Y
    Am J Kidney Dis; 2003 Jan; 41(1):244-9. PubMed ID: 12500244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case report of youth-onset lipoprotein glomerulopathy with APOE Chicago mutation.
    Liu Y; Cheng Y; Wen Y; Li C; Chen G; Li M
    BMC Nephrol; 2024 Mar; 25(1):87. PubMed ID: 38448817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein glomerulopathy resulting from compound heterogeneous mutations of APOE gene: A case report.
    Li Y; Chen J; Zou Y; Wang W; Li G
    Medicine (Baltimore); 2022 Feb; 101(5):e28718. PubMed ID: 35119017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy.
    Toyota K; Hashimoto T; Ogino D; Matsunaga A; Ito M; Masakane I; Degawa N; Sato H; Shirai S; Umetsu K; Tamiya G; Saito T; Hayasaka K
    J Hum Genet; 2013 May; 58(5):254-8. PubMed ID: 23407349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E-associated Lipoprotein Glomerulo-tubulopathy.
    Tanimizu H; Hara R; Sekine A; Inoue N; Hasegawa E; Tanaka K; Kono K; Kinowaki K; Ohashi K; Okubo M; Yamaguchi Y; Kang D; Honda K; Saito T; Sawa N; Ubara Y; Hoshino J
    Intern Med; 2023; 62(15):2209-2214. PubMed ID: 37532513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features.
    Saito T; Oikawa S; Sato H; Sato T; Ito S; Sasaki J
    Kidney Int Suppl; 1999 Jul; 71():S37-41. PubMed ID: 10412734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy.
    Arai T; Yamashita S; Yamane M; Manabe N; Matsuzaki T; Kiriyama K; Kanayama Y; Himeno S; Matsuzawa Y
    Atherosclerosis; 2003 Aug; 169(2):293-9. PubMed ID: 12921981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.
    Mitani A; Ishigami M; Watase K; Minakata T; Yamamura T
    J Atheroscler Thromb; 2011; 18(6):531-5. PubMed ID: 21325775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis, histopathologic findings and treatment modalities of lipoprotein glomerulopathy: A review.
    Cambruzzi E; Pêgas KL
    J Bras Nefrol; 2019; 41(3):393-399. PubMed ID: 30421781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
    Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC
    Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.